ConductScience.org, home

Paper7850784

Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: implications for the potential organization of the human von Hippel-Lindau disease gene.

Gao J and 5 others. Cancer Res, 1995. Cited by 50 papers, by iCite.

Cite this record

ConductScience Library. Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: implications for the potential organization of the human von Hippel-Lindau disease gene. Papers, record 7850784. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7850784

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: implications for the potential organization of the human von Hippel-Lindau disease gene.
PubMed
Journal
Cancer Res
PubMed
Year
1995
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
0.99
iCite
Revised in PubMed
2007-11-15
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gao JJ
2Naglich JGJ G
3Laidlaw JJ
4Whaley JMJ M
5Seizinger BRB R
6Kley NN

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genes, Tumor SuppressorMajor topic
von Hippel-Lindau DiseaseMajor topic
Amino Acid Sequence
Animals
Base Sequence
Blotting, Northern
Cloning, Molecular
DNA Probes
DNA, Complementary
Humans
Mice
Molecular Sequence Data
Open Reading Frames
RNA, Messenger
Sequence Homology, Nucleic Acid

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
41198931Oncostatin M induces epigenetic reprogramming in renal cell carcinoma-associated endothelial cells.Commun Biol2025https://conductscience.org/library/papers/41198931PubMed
21996733Complex cellular functions of the von Hippel-Lindau tumor suppressor gene: insights from model organisms.Oncogene2012https://conductscience.org/library/papers/21996733PubMed
18095884VHL inactivation in renal cell carcinoma: implications for diagnosis, prognosis and treatment.Expert Rev Anticancer Ther2008https://conductscience.org/library/papers/18095884PubMed
12844285Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia.Am J Hum Genet2003https://conductscience.org/library/papers/12844285PubMed
11420685Tumor suppressor protein VHL is induced at high cell density and mediates contact inhibition of cell growth.Oncogene2001https://conductscience.org/library/papers/11420685PubMed
11173562Recessive oncogenes: current status.Pathol Oncol Res1995https://conductscience.org/library/papers/11173562PubMed
10761708Germ-line mutation analysis in patients with von Hippel-Lindau disease in Japan: an extended study of 77 families.Jpn J Cancer Res2000https://conductscience.org/library/papers/10761708PubMed
10102622Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity.Oncogene1999https://conductscience.org/library/papers/10102622PubMed
9751722pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9751722PubMed
9671762A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9671762PubMed
9256442Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9256442PubMed
9205944The molecular basis of von Hippel-Lindau disease.Mol Med1997https://conductscience.org/library/papers/9205944PubMed
8700833Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8700833PubMed
7604013Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations.Proc Natl Acad Sci U S A1995https://conductscience.org/library/papers/7604013PubMed
7493907Cloning of the rat homologue of the von Hippel-Lindau tumor suppressor gene and its non-somatic mutation in rat renal cell carcinomas.Jpn J Cancer Res1995https://conductscience.org/library/papers/7493907PubMed

Download CSV of cited by

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
GENBANKS76748

Source GENBANK

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7850784

GET https://conductscience.org/api/papers/v1/7850784/authors